Blog.

Blog
hero
Why Use Technology in Arbitration for Document Production & Expert Review

Document production is becoming more common in arbitration today. Reliance on experts and other evidence to build and support a case has been and continues to be inevitable. Time and time again we see spiralling costs because parties live in the hope that a deep dive into the data will not be...

Read More
Blog
Gov Investigation
Creating a Defined Investigatory Process in Government Investigations

What sticks out from my time at the Department of Justice is this: should your organization receive a government subpoena, the government more likely than not already has the evidence they need to prove the violation. The subpoena, rather, is a tool to see how widespread this violation and others...

Read More
Blog
signapore
A Look Back: Three Takeaways from the AIJA Singapore Congress 2022 Keynote 

A season has passed since AIJA’s 60th Annual Congress in Singapore, providing a welcome opportunity to reflect on the event.

Read More
Blog
rectangle
Deploying TAR and Analytics in Merger Review Proceedings

On September 21, 2022, TransPerfect Legal hosted its second annual Antitrust Clearance & Merger Enforcement Conference in Washington, DC. Industry experts discussed a range of topics including substantive developments in antitrust law and legal tech and managed review in antitrust matters.

Read More
Blog
audio speaker
Searching Audio and Video Files: Are You Adequately Assessing Their Relevancy to Your Cases?

The COVID-19 pandemic augmented our increasingly virtual world. As such, the plethora of data at our fingertips has changed. Business Insider reported that Zoom meeting participants rose from 10 million in December 2019 to 300 million by April 2020. Although some in-person meetings have resumed,...

Read More
Blog
opera house
Key Takeaways from the 2022 General Counsel Summit

Senior lawyers from across Australia’s in-house legal community gathered at the General Counsel Summit in Sydney earlier this month. TransPerfect Legal sponsored the in-person event, itself exciting, and it was a pleasure to learn from a variety of speakers. Risk management, structuring internal...

Read More
Blog
hero image
TransPerfect Legal Interview Series Part 2: Marc Elshof

Introducing Marc Elshof, Co-Head of the European Technology, Media, and Telecommunications Sector Group at Dentons In part two of TransPerfect Legal Director of Business Development Dennis van de Schraaf's interview series, he speaks with Marc Elshof, Co-Head of the European Technology, Media and...

Read More
Blog
hero image
The ESI Protocol Explained

The ESI protocol is a negotiated document that expressly states how the parties to a litigation should produce electronically stored information (ESI). The ESI protocol assures against surprises and commands that ESI is preserved, collected, processed, and produced in an agreed upon, readily usable...

Read More
Blog
hero
TransPerfect Legal Interview Series Part 1: Tobias Kruis

TransPerfect Legal Interview Series Part 1: Tobias Kruis, Tech Data, a TD SYNNEX Company Dennis van de Schraaf, TransPerfect Legal Director of Business Development, recently interviewed Tobias Kruis, European Director of Ethics and Compliance and Global Competition Counsel at Tech Data, a TD...

Read More
Blog
hero
Quebec’s Bill 96: How We Can Help 

This past May, the Quebec government adopted Bill 96, with the intention of ultimately strengthening the Quebec language laws and preserving the French language. Although businesses with more than 50 employees were already subjected to many of the Charter laws, such as the Charter of the French...

Read More
Blog
hero image
Three Keys to Substantial Compliance in Cross-Border Mergers and Acquisitions

Cross-border M&A deals reached an all-time high of $2.1 trillion in 2021. Many of these transactions were subjected to merger clearance proceedings in the US and/or abroad. As a result, an unprecedented number of US second requests, Canadian SIRs, and EC Phase II proceedings involved large...

Read More
Blog
ip-lifesci
Intellectual Property (IP) Strategies to Consider for Life Sciences Start-Ups

Intellectual property (IP) is one of the most valuable assets a life sciences innovator or start-up has. While these companies are often built on the foundations of successful pre-clinical studies, they face a substantial amount of time between obtaining regulatory approvals and introducing a drug...

Read More